Evidence map›Paper›PMID 37058471›Full record

ArticleDiabetes2023

Dysregulation of CXCL1 Expression and Neutrophil Recruitment in Insulin Resistance and Diabetes-Related Periodontitis in Male Mice.

Takanori Shinjo, Satoru Onizuka, Yumi Zaitsu, Atsushi Ishikado, Kyoungmin Park, Qian Li, Hisashi Yokomizo, Tatsuro Zeze, Kohei Sato, Ronald St-Louis and 7 more

Open access · greenAbstract read
In one paragraph

Article in Diabetes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Takanori ShinjoSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Satoru OnizukaSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Yumi ZaitsuSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Atsushi IshikadoSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Kyoungmin ParkSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Qian LiSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Hisashi YokomizoSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Tatsuro ZezeSection of Periodontology, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
Kohei SatoSection of Periodontology, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.
Ronald St-LouisSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Jialin FuSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Wu I-HsienSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.
Koji MizutaniDepartment of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Hatice HasturkDepartment of Applied Oral Science, The Forsyth Institute, Cambridge, MA.
Thomas E Van DykeDepartment of Applied Oral Science, The Forsyth Institute, Cambridge, MA.
Fusanori NishimuraSection of Periodontology, Faculty of Dental Science, Kyushu University, Fukuoka, Japan.ORCID 0000-0003-1572-2180
George L KingSection of Vascular Cell Biology, Joslin Diabetes Center, Harvard Medical School, Boston, MA.ORCID 0000-0002-0335-5881
Joslin Diabetes Center · USKyushu University · JPTokyo Medical and Dental University · JP

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
SELECTIVE INSULIN RESISTANCE--DIABETIC VASCULAR DISEASER01DK053105 · NIDDK · JOSLIN DIABETES CENTER · PI KING, GEORGE L · 1997 to 2017
$5.0M
Validation of Potential Protective Factors from Diabetic ComplicationsDP3DK094333 · NIDDK · JOSLIN DIABETES CENTER · PI KING, GEORGE L · 2011 to 2015
$4.1M
NIDDK NIH HHS DP3 DK094333NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK053105
6 · The paper itself

Abstract

Insulin resistance and hyperglycemia are risk factors for periodontitis and poor wound healing in diabetes, which have been associated with selective loss of insulin activation of the PI3K/Akt pathway in the gingiva. This study showed that insulin resistance in the mouse gingiva due to selective deletion of smooth muscle and fibroblast insulin receptor (SMIRKO mice) or systemic metabolic changes induced by a high-fat diet (HFD) in HFD-fed mice exacerbated periodontitis-induced alveolar bone loss, preceded by delayed neutrophil and monocyte recruitment and impaired bacterial clearance compared with their respective controls. The immunocytokines, CXCL1, CXCL2, MCP-1, TNFα, IL-1β, and IL-17A, exhibited delayed maximal expression in the gingiva of male SMIRKO and HFD-fed mice compared with controls. Targeted overexpression of CXCL1 in the gingiva by adenovirus normalized neutrophil and monocyte recruitment and prevented bone loss in both mouse models of insulin resistance. Mechanistically, insulin enhanced bacterial lipopolysaccharide-induced CXCL1 production in mouse and human gingival fibroblasts (GFs), via Akt pathway and NF-κB activation, which were reduced in GFs from SMIRKO and HFD-fed mice. These results provided the first report that insulin signaling can enhance endotoxin-induced CXCL1 expression to modulate neutrophil recruitment, suggesting CXCL1 as a new therapeutic direction for periodontitis or wound healing in diabetes. ARTICLE HIGHLIGHTS: The mechanism for the increased risks for periodontitis in the gingival tissues due to insulin resistance and diabetes is unclear. We investigated how insulin action in gingival fibroblasts modulates the progression of periodontitis in resistance and diabetes. Insulin upregulated the lipopolysaccharide-induced neutrophil chemoattractant, CXCL1, production in gingival fibroblasts via insulin receptors and Akt activation. Enhancing CXCL1 expression in the gingiva normalized diabetes and insulin resistance-induced delays in neutrophils recruitment and periodontitis. Targeting dysregulation of CXCL1 in fibroblasts is potentially therapeutic for periodontitis and may also improve wound healing in insulin resistance and diabetes.

Indexed as

Diabetes MellitusInsulin ResistanceInsulinsPeriodontitisAnimalsChemokine CXCL1HumansLipopolysaccharidesMaleMiceNeutrophil InfiltrationPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktChemokine CXCL1CXCL1 protein, humanInsulinsLipopolysaccharidesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Identifiers

PMID37058471
PMCPMC10281234
OpenAlexW4365479524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.